<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36977491</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-3646</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association</Title><ISOAbbreviation>Exp Clin Endocrinol Diabetes</ISOAbbreviation></Journal><ArticleTitle>Metabolic and Endocrine Complications of Long-COVID-19: A Review.</ArticleTitle><Pagination><StartPage>367</StartPage><EndPage>374</EndPage><MedlinePgn>367-374</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-2063-8697</ELocationID><Abstract><AbstractText>Over the past two years, the outbreak of coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has centralized the interest of the health care systems and the scientific world. The majority of COVID-19-infected individuals recover fully. However, about 12-50% of patients experience various mid- and long-term effects after recovering from the initial illness. These mid- and long-term effects are collectively known as post-COVID-19 condition or 'long-COVID'. In the coming months, the long-term consequences of COVID-19 on the metabolic and endocrine systems may expect to rise and pose a global healthcare challenge. This review article discusses the possible metabolic and endocrine complications of long-COVID and the relevant research findings.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bandara</LastName><ForeName>Thushari</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Academic Diabetes, Endocrinology, and Metabolism, Allam Diabetes Centre, Hull York Medical School, University of Hull, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deshmukh</LastName><ForeName>Harshal A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Academic Diabetes, Endocrinology, and Metabolism, Allam Diabetes Centre, Hull York Medical School, University of Hull, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdalla</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Academic Diabetes, Endocrinology, and Metabolism, Allam Diabetes Centre, Hull York Medical School, University of Hull, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathyapalan</LastName><ForeName>Thozhukat</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Academic Diabetes, Endocrinology, and Metabolism, Allam Diabetes Centre, Hull York Medical School, University of Hull, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hull University Teaching Hospitals NHS Trust, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Exp Clin Endocrinol Diabetes</MedlineTA><NlmUniqueID>9505926</NlmUniqueID><ISSNLinking>0947-7349</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004703" MajorTopicYN="N">Endocrine System</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>19</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36977491</ArticleId><ArticleId IdType="doi">10.1055/a-2063-8697</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>